Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-97.94	73.51	3570.11
Graham Fair Price	-70.63	2.58	8.78
PEG	-12512.45	-0.27	< 0.005
Price/Book	-33.06	1.91	2.86
Price/Cash Flow	-15.72	-93.33	-80.65
Prices/Earnings	691.12	28.82	-3.64
Price/Sales	-43.72	5.85	10.39
Price/FCF	-15.72	-93.33	-80.65
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	129.67	0.14	0.06
Operating Margin	-92.72	0.06	-0.87
ROA	-91.37	0.01	-0.12
ROE	-0.20	0.02	-91.54
ROIC	-0.19	0.01	-92.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.12	-0.06	-96.34
Dividends QOQ	-0.14	-0.59	-308.41
EBIT QOQ	-13.12	1.09	-91.70
EPS QOQ	-17.30	1.09	-93.73
FCF QOQ	0.17	0.41	139.31
Revenue QOQ	-0.41	0.21	-49.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	24.81	16.37	-34.02
Days Sales Outstanding (DSO)	109.93	95.96	-12.71
Inventory Turnover	3.63	5.50	51.55
Debt/Capitalization	0.23	0.20	-10.61
Quick Ratio	1.37	1.38	0.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.18	4.22	0.97
Cash	1.75	1.57	-10.60
Capex	-0.30	-0.18	40.76
Free Cash Flow	-0.15	-0.09	41.60
Revenue	1.15	1.38	20.09
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.57	1.56	-0.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-165.15	-4.80	97.09
Naive Interpretation	Member

06 - Financial Health · Weak

Rating